Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Leonard Schleifer, the founder and CEO of Regeneron Pharmaceuticals, said on Sunday that President Trump's successful treatment with the company's antibody cocktail is "the weakest evidence you can get" on whether the drug is a cure.

Driving the news: Since leaving Walter Reed Medical Center on Monday, Trump has repeatedly claimed that he is "immune" from COVID-19 and said he views the antibody cocktail as a "cure."

What they're saying: “The president’s case is a case of one, and that’s what we call a case report. And it is evidence of what's happening, but it’s kind of the weakest evidence that you can get," Schleifer told CBS News' "Face the Nation."

  • “[T]he real evidence about how good a drug is and what it will do on average has to come from these larger clinical trials, these randomized clinical trials, which are the gold standard, and those are ongoing," he said.
  • The president’s case is “just low down on the evidence scale that we really need," and while the drug does create immunity, "it's probably going to last you for months," Schleifer added.

The bottom line: “Regeneron can’t do this alone. We need the entire industry. And I am so proud the industry has risen,” Schleifer said.

What to watch: Regeneron and Eli Lilly, which is developing a similar therapy, have applied for an emergency use authorization from the FDA.

Go deeper: Ex-FDA chief says Trump "definitely missed the window" to mass produce antibody drug

Go deeper

Dan Primack, author of Pro Rata
Jan 14, 2021 - Podcasts

The vaccine pipeline, beyond Pfizer and Moderna

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity.

Axios Re:Cap digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.

Jan 14, 2021 - Health

WHO team arrives in China to investigate pandemic origins

Health workers at a cordoned-off section of the international airport in Wuhan, China, as the World Health Organization team arrives on Thursday. Photo: Nicolas Asfouri/AFP via Getty Images

A World Health Organization team of researchers arrived in Wuhan, China, Thursday ahead of their investigation into the origins of the COVID-19 pandemic.

Driving the news: Dominic Dwyer, a Sydney virologist based who's among the scientists on the visit, told the Australian Broadcasting Corporation they don't expect to find a "patient zero." "But we may have a much better indication of whether the virus truly started in Wuhan," he said.

Jan 14, 2021 - Health

Coronavirus deaths climbing while country deals with political unrest

Expand chart
Data: The COVID Tracking Project; Map: Andrew Witherspoon/Axios

Coronavirus deaths continue to reach tragic heights while the country grapples with a vaccine rollout, an impeachment and ongoing civil unrest.